Haiquan Chen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Immunotherapy in Uncommon and 20ins EGFR-mut Lung Cancers (NCT06164574) | Haiquan Chen | 2022-11-01 |
Track Haiquan Chen automatically
Every clearance here is in the API, with alerts when new ones post.